IFNG and neoplasm: IFN-γ-induced upregulation of PD-L1 expression on immune and tumor target cells is recognized as a conserved mechanism of adaptive immune resistance and tolerance as a response to chronic antigen stimulation, which is observed in both cancers and chronic pathogen exposure (15–17).